Taiwan Cannabis Cultivation Market Size & Outlook, 2026-2034

Taiwan Cannabis Cultivation Market Insights

Based on Deep Market Insights findings, the Taiwan Cannabis Cultivation Market reached USD 325.06 Million in 2025 and is estimated to attain USD 818.2 Million by 2034.
From 2026 to 2034, the Taiwan market is expected to grow at a steady CAGR of 10.71%.
Within the By Type category, Medical cannabis dominated in 2025 in terms of market size contribution.
Over the forecast period, Medical cannabis is forecasted to deliver the fastest growth, positioning it as the most lucrative By Type segment.

As of 2025, Taiwan held 1.26% of the global Cannabis Cultivation Market size.
By 2034, United States is anticipated to capture the largest share of the global Cannabis Cultivation Market.
In Asia Pacific, China is expected to lead the regional Cannabis Cultivation Market size by 2034.
Japan will remain the fastest-growing market in Asia Pacific, reaching USD 2012.08 Million by 2034.

Report Scope	Details
Base Year for Study	2025
Study Period	2022-2034
Historical Period	2022-2024
Forecast Period	2026-2034
Market Size In 2025	USD 325.06 Million
Market Size In 2034	USD 818.2 Million
Largest segment	Medical cannabis
Units	Revenue in USD Million
CAGR	10.71% (2026-2034)
Segmnetation Covered
By Type	Medical cannabis Industrial hemp Recreational cannabis CBD-rich cannabis
By Cultivation Method	Indoor cultivation Outdoor cultivation Greenhouse cultivation Hydroponic cultivation
By Application	Pharmaceuticals Recreational use Food & beverages Cosmetics
By End User	Commercial growers Research institutions Pharmaceutical companies Consumers
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

By Type	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033	2034
Medical cannabis	XX.x	XX.x	XX.x	149.33	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Industrial hemp	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Recreational cannabis	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
CBD-rich cannabis	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: DMI Analysis Company Publications, Primary Interviews.

By Cultivation Method	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033	2034
Indoor cultivation	XX.x	XX.x	XX.x	143.16	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Outdoor cultivation	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Greenhouse cultivation	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Hydroponic cultivation	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: DMI Analysis Company Publications, Primary Interviews.

By Application	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033	2034
Pharmaceuticals	XX.x	XX.x	XX.x	162.17	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Recreational use	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Food & beverages	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Cosmetics	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: DMI Analysis Company Publications, Primary Interviews.

By End User	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033	2034
Commercial growers	XX.x	XX.x	XX.x	142.54	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Research institutions	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Pharmaceutical companies	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Consumers	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x